A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D012008:Recurrence
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007978:Levamisole; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D001379:Azathioprine